House Bill No. [insert bill number] aims to enhance health insurance coverage for genetic testing and treatment related to SCN2A-associated medical conditions. The bill mandates that any health coverage plan issued or renewed in Louisiana on or after January 1, 2027, must provide coverage for genetic testing when ordered by a treating physician or advanced practice provider. Additionally, it requires coverage for medically necessary treatments associated with SCN2A conditions, which may include anti-seizure medications, rehabilitative services, durable medical equipment, and other necessary treatments as determined by the healthcare provider.

The bill also establishes guidelines for determining medical necessity, requiring that any denial of coverage be communicated in writing with clear reasoning, and allows for appeals of such denials. It permits prior authorization for services, provided that these procedures are applied fairly and consistently with other benefits. Furthermore, the bill prohibits denial of coverage based on disability, developmental status, or pre-existing conditions, and clarifies that the mandated benefits will be considered essential health benefits. However, it does not apply to limited benefit health insurance policies or contracts. The provisions of this bill will take effect upon the governor's signature or after the designated time for gubernatorial action.